ENAGenomicsBRIGHAM AND WOMEN'S HOSPITALhttps://www.ebi.ac.uk/ena/browser/view/PRJNA755359Homo sapiensA rapid, sensitive, low-cost diagnostic device for early detection of novel Coronavirus Disease (COVID-19) could significantly change the paradigm in real-time and efficient management of patients and available healthcare resources, specifically during this time of increased demand for hospital services. The quantitative real-time polymerase chain reaction (qPCR) represents the most important method for the diagnosis of COVID-19 at its early stage of infection and before the appearance of clinical symptoms. However, qPCR-based molecular diagnostics are bulky, expensive, lab-based, and require trained personnel for system operation. The majority of the FDA EUA-approved COVID-19 diagnostics are PCR-based, which require nucleic acid extraction, followed by amplification via thermal cycling... (for more see dbGaP study page.)ENAfalseRapid Acceleration of Diagnostics - Radical (RADx-rad): A Rapid, Sensitive, Point-of- care, Antigen-based Diagnostics for SARS-CoV-2Rapid Acceleration of Diagnostics - Radical (RADx-rad): A Rapid, Sensitive, Point-of- care, Antigen-based Diagnostics for SARS-CoV-22025-09-242022-11-24PRJNA7553599606